Cefepime for Ceftriaxone-Resistant Enterobacterales With Chromosomal AmpC β-Lactamases
Clin Infect Dis
.
2023 Jul 5;77(1):162-163.
doi: 10.1093/cid/ciad173.
Authors
Matthew W Davis
1
,
Abriana C Holzworth
1
,
Caleb E Rux
1
,
Dayna McManus
1
,
Jeffrey E Topal
1
2
Affiliations
1
Department of Pharmacy, Yale-New Haven Hospital, New Haven, Connecticut, USA.
2
Department of Internal Medicine, Section of Infectious Diseases, Yale School of Medicine, New Haven, Connecticut, USA.
PMID:
36974628
DOI:
10.1093/cid/ciad173
No abstract available
Publication types
Letter
Comment
MeSH terms
Bacterial Proteins / genetics
Cefepime / pharmacology
Ceftriaxone* / pharmacology
Humans
beta-Lactamases* / genetics
Substances
Cefepime
AmpC beta-lactamases
Ceftriaxone
beta-Lactamases
Bacterial Proteins